Bair Teresa Brophy 4
4 · Kura Oncology, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Bair Teresa Brophy
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-05-20$22.15/sh−2,615$57,916→ 68,979 total
Footnotes (4)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023.
- [F2]2615 shares were acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The reported sale of 2,615 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023.